MedPath
HSA Approval

TRENLIN 400 SR TABLET 400 mg

SIN10727P

TRENLIN 400 SR TABLET 400 mg

TRENLIN 400 SR TABLET 400 mg

February 8, 1999

DUOPHARMA (SINGAPORE) PTE LTD

DUOPHARMA (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantDUOPHARMA (SINGAPORE) PTE LTD
Licence HolderDUOPHARMA (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

C04AD03

pentoxifylline

Manufacturer Information

DUOPHARMA (SINGAPORE) PTE. LTD.

DUOPHARMA MANUFACTURING (BANGI) SDN.BHD.

Active Ingredients

PENTOXIFYLLINE

400 mg

Pentoxifylline

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

TRENLIN 400 SR TABLET 400 mg - HSA Approval | MedPath